RELMADA THERAPEUTICS, INC. - RLMD
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Spruce Street Capital LP | 5.57% | 4,086,181 | View |
| Feb 17, 2026 | SCHEDULE 13G | Alex R. Rosen | 5.57% | 4,086,181 | View |
| Feb 17, 2026 | SCHEDULE 13G | Simon Basseyn | 5.57% | 4,086,181 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Master Fund LP | 9.9% | 7,395,510 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Capital Management LLC | 9.9% | 7,395,510 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | William Blank | 9.9% | 7,395,510 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Matthew Sesterhenn | 9.9% | 7,395,510 | View |
| Feb 12, 2026 | SCHEDULE 13G | Adage Capital Management, L.P. | 5.82% | 4,270,000 | View |
| Feb 12, 2026 | SCHEDULE 13G | Robert Atchinson | 5.82% | 4,270,000 | View |
| Feb 12, 2026 | SCHEDULE 13G | Phillip Gross | 5.82% | 4,270,000 | View |
| Feb 06, 2026 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 10.1% | 7,439,415 | View |
| Nov 14, 2025 | SCHEDULE 13G | Ikarian Capital, LLC | 4.8% | 3,543,359 | View |
| Nov 14, 2025 | SCHEDULE 13G | Neil Shahrestani | 4.8% | 3,543,359 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.